Optimizing HSCT in Blood Cancers
From Treating Blood Cancers by Blood Cancer United
June 2, 2026 · 39 min
About this episode
Dr. Lori Muffly discusses the role of HSCT in blood cancer treatment and recent advances in the field.
Lori Muffly MD, MS, Stanford Medicine, Stanford, CA Recorded on May 12, 2026 Lori Muffly MD, MS Professor of Medicine Division of Blood and Marrow Transplantation & Cellular Therapy Stanford Medicine Stanford, CA In this episode, Dr. Lori Muffly from Stanford Medicine explores how hematopoietic stem cell transplantation (HSCT) continues to play a central role in care, even as cellular therapies evolve. She also discusses recent advances in overall survival and graft versus host disease as well as clinical trials. We also explore barriers to access, the importance of multidisciplinary teams, and resources to support patients and healthcare professionals. Join us for this insightful episode on the important role of HSCT today, and where it’s headed next. Mentioned on this episode: www.NMDP.org www.hematology.org Additional Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients
People in this episode
Guest: Lori Muffly MD, MS
Topics covered
- hematopoietic stem cell transplantation
- blood cancers
- cellular therapies
- clinical trials
- graft versus host disease
- multidisciplinary teams
Keywords
- HSCT
- blood cancers
- cellular therapies
- graft versus host disease
- clinical trials
- patient resources
Mentioned in this episode
Organizations: Stanford Medicine, NMDP, hematology.org, Blood Cancer United
More episodes of Treating Blood Cancers
- Clinical Strategies for Supporting Couples, Care Partners, and Families in Oncology Care · May 8, 2026 · 35 min
- Driving Progress in AML · April 23, 2026 · 34 min
- Redefining Normal: Clinical Insights for Healthcare Professionals Supporting Survivors After Treatment · April 13, 2026 · 34 min
- Optimizing Outcomes in Myeloma · March 24, 2026 · 40 min
- Strategies to Navigate Expanded Access (Compassionate Use) in Treating Pediatric Oncology · March 3, 2026 · 40 min
- What’s New and What’s Next in CLL · February 17, 2026 · 39 min
Explore listener stats, chart rankings, contacts and more on the Treating Blood Cancers podcast page.